Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Receives Average Recommendation of “Reduce” from Brokerages

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) has been assigned an average rating of “Reduce” from the nine analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating and eight have given a hold rating to the company.

Several research firms recently weighed in on BAYRY. Citigroup restated a “neutral” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, February 29th. Wolfe Research lowered shares of Bayer Aktiengesellschaft from an “outperform” rating to a “peer perform” rating in a research report on Tuesday, January 30th. Finally, Sanford C. Bernstein reiterated a “market perform” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, March 7th.

Bayer Aktiengesellschaft Trading Down 2.2 %

Shares of BAYRY stock opened at $7.02 on Friday. The firm has a 50-day moving average of $7.47 and a 200-day moving average of $8.93. The company has a current ratio of 1.27, a quick ratio of 0.80 and a debt-to-equity ratio of 1.15. Bayer Aktiengesellschaft has a one year low of $6.96 and a one year high of $16.94.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its earnings results on Tuesday, March 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.38 by $0.12. The company had revenue of $12.77 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 6.31% and a positive return on equity of 17.27%. On average, equities research analysts anticipate that Bayer Aktiengesellschaft will post 1.36 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Cuts Dividend

The company also recently announced a dividend, which will be paid on Monday, May 13th. Stockholders of record on Tuesday, April 30th will be issued a $0.0191 dividend. The ex-dividend date of this dividend is Monday, April 29th. Bayer Aktiengesellschaft’s dividend payout ratio is -54.88%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.